
- Volume 0 0
Gene Variation Associated with OA in Women
Researchers have found that a variantin the FRZB gene may increase thechances of osteoarthritis (OA) in women.The study involved analyzing deoxyribonucleicacid from pairs of siblings withOA. The results showed that a single nucleotidechange in FRZB correspondedstrongly with OA in women.
The FRZB gene codes for a protein thatregulates a signaling pathway that is crucialin skeletal and joint development. Theprotein produced by the variant version ofFRZB cannot perform the duties of thenormal protein, according to the study reportedrecently in the Proceedings of theNational Academy of Sciences. Theresearchers suggested that this variantversion of FRZB may upset the properdevelopment of joint cartilage and/orbone, making women with the variantmore at risk for OA in the hip. If detectedearly, this gene variant may aid in prevention,treatment, and development of futuretreatments for OA.
Articles in this issue
over 21 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationover 21 years ago
System Improves Productivity, Drug Verificationover 21 years ago
COMPOUNDING HOTLINEover 21 years ago
Cardinal Introduces PatientPAK 340Bover 21 years ago
Obesity Is an Addiction, Researchers Sayover 21 years ago
Scientists Seek to Understand How Fat Causes Cancerover 21 years ago
Government Plans Attack on Obesityover 21 years ago
Gene Discovery May Unlock Key to Obesity Syndromeover 21 years ago
Consuming Fruit, Not Fat, Staves Off Weight GainNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.










































































































































































































